Author:
Shey Muki,Kongnyuy Eugene J,Shang Judith,Wiysonge Charles Shey
Reference32 articles.
1. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection;Gulick;N Engl J Med,2004
2. A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity;Kumar;HIV Med,2006
3. A randomized, controlled trial of initial anti-retroviral therapy with abacavir/Lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESSI00327, the ACTION Study);Kumar;AIDS Research and Therapy,2009
4. Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy;Ait-Khaled;Antivir Ther,2002
5. Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine;Cahn;Curr Med Res Opin,2004
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献